Cargando…
Leukocyte Cell‐Derived Chemotaxin‐2: It's Role in Pathophysiology and Future in Clinical Medicine
Autores principales: | Slowik, V, Apte, U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504477/ https://www.ncbi.nlm.nih.gov/pubmed/28466965 http://dx.doi.org/10.1111/cts.12469 |
Ejemplares similares
-
Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis
por: Kulkarni, Uday, et al.
Publicado: (2015) -
Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2014) -
Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
por: He, Wen-Ming, et al.
Publicado: (2019) -
Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report
por: Kaur, Gagandeep, et al.
Publicado: (2017) -
Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice
por: Kikuchi, Akihiro, et al.
Publicado: (2020)